Previous studies have observed that HDAC inhibitors significantly suppressed the migration and invasion of prostate cancer cells, which is corrected by knockdown of E-cadherin, suggesting a possible mechanism of E-cadherin in HDAC inhibitors regulating migration and invasion [37]. This evidence concerns the gene CDH1 and prostate cancer.